Cargando…
Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis
Tumor necrosis factor-stimulated gene-6 (TSG-6) is a 35-kDa glycoprotein that has been shown to exert anti-inflammatory effects in experimental models of arthritis, acute myocardial infarction, and acute cerebral infarction. Several lines of evidence have shed light on the pathophysiological roles o...
Autores principales: | Watanabe, Rena, Sato, Yuki, Ozawa, Nana, Takahashi, Yui, Koba, Shinji, Watanabe, Takuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855687/ https://www.ncbi.nlm.nih.gov/pubmed/29401724 http://dx.doi.org/10.3390/ijms19020465 |
Ejemplares similares
-
Atheroprotective Effects of Tumor Necrosis Factor–Stimulated Gene-6
por: Watanabe, Rena, et al.
Publicado: (2016) -
Neopterin Counters Vascular Inflammation and Atherosclerosis
por: Shirai, Remina, et al.
Publicado: (2018) -
Vasoprotective Effects of Urocortin 1 against Atherosclerosis In Vitro and In Vivo
por: Hasegawa, Akinori, et al.
Publicado: (2014) -
Legumain Promotes Atherosclerotic Vascular Remodeling
por: Ozawa, Nana, et al.
Publicado: (2019) -
The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease
por: Watanabe, Takuya
Publicado: (2021)